Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TSE:HLS
Stock Latest News
The Fly
HLS Therapeutics resumed with a Hold at Canaccord
6d ago
Premium
Ratings
HLS Therapeutics: Buy Rating Reiterated as Analyst Sees Nilemdo Upside with Unchanged $12 Price Target
6d ago
Premium
Pre-Earnings
HLS Earnings this Week: How Will it Perform?
12d ago
Premium
Company Announcements
HLS Therapeutics to Highlight CNS and Cardiovascular Portfolio at Bloom Burton Investor Conference
1M ago
Premium
Ratings
HLS Therapeutics: Near-Term Softness Masking NILEMDO-Driven Growth Upside, Supporting Buy Rating
2M ago
Premium
The Fly
HLS Therapeutics price target lowered to C$4.45 from C$4.75 at Stifel
2M ago
Premium
Company Announcements
HLS Therapeutics Lifts Profitability, Cuts Debt as It Expands Cardiovascular Portfolio
2M ago
Premium
Pre-Earnings
Is HLS a Buy, Before Earnings?
3M ago
Premium
Company Announcements
HLS Therapeutics launches NILEMDO in Canada to tackle unmet cholesterol treatment needs
3M ago
Premium
Company Announcements
HLS Therapeutics launches NILEMDO in Canada to target unmet LDL-cholesterol needs
3M ago
Premium
Company Announcements
HLS Therapeutics Sets March 12 Date for Fiscal 2025 Results and Investor Call
3M ago
Premium
The Fly
HLS Therapeutics price target raised to C$4.75 from C$4 at Stifel
5M ago
Premium
Ratings
Positive Outlook for HLS Therapeutics Inc. Amid Regulatory Developments and Product Approvals
6M ago
Premium
Company Announcements
HLS Therapeutics Gains Health Canada Approval for NILEMDO®
6M ago
Premium
Ratings
HLS Therapeutics Inc.: Strategic Resilience and Growth Potential Amidst Market Challenges
6M ago
Premium
Company Announcements
HLS Therapeutics Reports Mixed Earnings Amid Growth Challenges
6M ago
Premium
Company Announcements
HLS Therapeutics Reports Strong Q3 2025 Results and Prepares for New Product Launch
6M ago
Premium
Pre-Earnings
HLS Upcoming Earnings Report: What to Expect?
7M ago
Premium
Company Announcements
HLS Therapeutics to Announce Q3 2025 Financial Results
7M ago
Premium
Company Announcements
HLS Therapeutics and Amarin Highlight Cardiovascular Advances at Canadian Congress
7M ago
Premium
Company Announcements
HLS Therapeutics Secures New Credit Agreement for Financial Flexibility
9M ago
Premium
Ratings
HLS Therapeutics Inc: Strong Q2 Performance and Optimistic Outlook Justify Buy Rating
9M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
